Skip to main content

Table 3 Visibility score

From: Nomegestrol acetate versus combined oral contraceptive as rapid endometrial preparation for operative hysteroscopy: a prospective randomised pilot study

Visibility score

Group A (n = 21), NOMAC

Group B (n = 21), EE/GSD

P value

Bad visibility

3 (14 %)

0 (0 %)

0.06

Moderate visibility

6 (28 %)

3 (14 %)

0.08

Good visibility

12 (58 %)

18 (86 %)

0.002

  1. NOMAC 5 μg nomegestrol acetate, EE/GSD 20μg ethinyl estradiol/75 mg gestodene
Back to article page